JP2018537754A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537754A5
JP2018537754A5 JP2018517870A JP2018517870A JP2018537754A5 JP 2018537754 A5 JP2018537754 A5 JP 2018537754A5 JP 2018517870 A JP2018517870 A JP 2018517870A JP 2018517870 A JP2018517870 A JP 2018517870A JP 2018537754 A5 JP2018537754 A5 JP 2018537754A5
Authority
JP
Japan
Prior art keywords
subject
genetic information
genetic
disease
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018517870A
Other languages
English (en)
Japanese (ja)
Other versions
JP6991134B2 (ja
JP2018537754A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/056131 external-priority patent/WO2017062867A1/en
Publication of JP2018537754A publication Critical patent/JP2018537754A/ja
Publication of JP2018537754A5 publication Critical patent/JP2018537754A5/ja
Priority to JP2021198384A priority Critical patent/JP7536738B2/ja
Application granted granted Critical
Publication of JP6991134B2 publication Critical patent/JP6991134B2/ja
Priority to JP2024130854A priority patent/JP2024167909A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018517870A 2015-10-09 2016-10-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ Active JP6991134B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021198384A JP7536738B2 (ja) 2015-10-09 2021-12-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
JP2024130854A JP2024167909A (ja) 2015-10-09 2024-08-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562239390P 2015-10-09 2015-10-09
US62/239,390 2015-10-09
PCT/US2016/056131 WO2017062867A1 (en) 2015-10-09 2016-10-07 Population based treatment recommender using cell free dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021198384A Division JP7536738B2 (ja) 2015-10-09 2021-12-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ

Publications (3)

Publication Number Publication Date
JP2018537754A JP2018537754A (ja) 2018-12-20
JP2018537754A5 true JP2018537754A5 (https=) 2019-11-14
JP6991134B2 JP6991134B2 (ja) 2022-01-12

Family

ID=58488667

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018517870A Active JP6991134B2 (ja) 2015-10-09 2016-10-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
JP2021198384A Active JP7536738B2 (ja) 2015-10-09 2021-12-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
JP2024130854A Pending JP2024167909A (ja) 2015-10-09 2024-08-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021198384A Active JP7536738B2 (ja) 2015-10-09 2021-12-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
JP2024130854A Pending JP2024167909A (ja) 2015-10-09 2024-08-07 無細胞ｄｎａを使用する集団ベースの処置レコメンダ

Country Status (5)

Country Link
US (3) US11756655B2 (https=)
EP (2) EP3359694A4 (https=)
JP (3) JP6991134B2 (https=)
CN (2) CN116640849A (https=)
WO (1) WO2017062867A1 (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
CN111254500B (zh) 2012-12-10 2024-01-23 分析生物科学有限公司 靶向基因组分析的方法
US20160053301A1 (en) 2014-08-22 2016-02-25 Clearfork Bioscience, Inc. Methods for quantitative genetic analysis of cell free dna
EP3766986B1 (en) * 2014-12-31 2022-06-01 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
JP6991134B2 (ja) * 2015-10-09 2022-01-12 ガーダント ヘルス， インコーポレイテッド 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
JP6913089B2 (ja) 2015-11-11 2021-08-04 レゾリューション バイオサイエンス， インコーポレイテッド Ｄｎａライブラリーの高効率構築
CN116640847A (zh) 2016-02-02 2023-08-25 夸登特健康公司 癌症进化检测和诊断
US11384382B2 (en) 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
ES3002715T3 (en) 2016-04-14 2025-03-07 Guardant Health Inc Methods for early detection of cancer
US20190287645A1 (en) * 2016-07-06 2019-09-19 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
US11319594B2 (en) 2016-08-25 2022-05-03 Resolution Bioscience, Inc. Methods for the detection of genomic copy changes in DNA samples
EP3461274B1 (en) 2016-09-30 2020-11-04 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
CN107437004B (zh) * 2017-08-07 2020-06-19 深圳华大基因研究院 一种用于肿瘤个体化基因检测智能解读的系统
CN111526793A (zh) 2017-10-27 2020-08-11 朱诺诊断学公司 用于超低体积液体活检的设备、系统和方法
CA3083792A1 (en) * 2017-12-18 2019-06-27 Personal Genome Diagnostics Inc. Machine learning system and method for somatic mutation discovery
US12462935B2 (en) 2018-03-30 2025-11-04 Nucleix Ltd. Deep learning-based methods, devices, and systems for prenatal testing
WO2019200398A1 (en) * 2018-04-13 2019-10-17 Dana-Farber Cancer Institute, Inc. Ultra-sensitive detection of cancer by algorithmic analysis
JP7455757B2 (ja) 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装
JP2019213473A (ja) * 2018-06-12 2019-12-19 国立大学法人 鹿児島大学 膵腫瘍摘出術後予後リスク判別法
CN111919257B (zh) * 2018-07-27 2021-05-28 思勤有限公司 降低测序数据中的噪声的方法和系统及其实施和应用
CN109344017A (zh) * 2018-09-06 2019-02-15 浪潮电子信息产业股份有限公司 一种基于机器学习预测内存故障的方法，设备及可读存储介质
WO2020077232A1 (en) * 2018-10-12 2020-04-16 Cambridge Cancer Genomics Limited Methods and systems for nucleic acid variant detection and analysis
US20250279214A1 (en) * 2018-10-17 2025-09-04 Tempus Ai, Inc. Cancer treatment efficacy evaluation upon undergoing or completing a cancer treatment
CN109271374B (zh) * 2018-10-19 2021-01-26 国网江苏省电力有限公司信息通信分公司 一种基于机器学习的数据库健康度打分方法和打分系统
WO2020086433A1 (en) * 2018-10-22 2020-04-30 The Jackson Laboratory Methods and apparatus for phenotype-driven clinical genomics using a likelihood ratio paradigm
AU2019401636A1 (en) * 2018-12-18 2021-06-17 Grail, Llc Systems and methods for estimating cell source fractions using methylation information
AU2019418813A1 (en) * 2018-12-31 2021-07-22 Tempus Ai, Inc. A method and process for predicting and analyzing patient cohort response, progression, and survival
US11875903B2 (en) 2018-12-31 2024-01-16 Tempus Labs, Inc. Method and process for predicting and analyzing patient cohort response, progression, and survival
CN109829425B (zh) * 2019-01-31 2020-12-22 沈阳农业大学 一种农田景观小尺度地物分类方法及系统
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
JP7621967B2 (ja) * 2019-03-28 2025-01-27 フェーズ ゲノミクス インコーポレイテッド シーケンシングによる核型分析のためのシステムおよび方法
US11676727B2 (en) 2019-08-14 2023-06-13 Optum Technology, Inc. Cohort-based predictive data analysis
EP3809414A1 (en) * 2019-10-15 2021-04-21 Koninklijke Philips N.V. Method and apparatus for assessing patient's response to therapy
JP7745265B2 (ja) * 2019-12-27 2025-09-29 ベトロジー イノベーションズ，エルエルシー． 予測モデルを組み合わせた画像の効率的な人工知能分析
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
CN111584002B (zh) * 2020-05-22 2022-04-29 至本医疗科技（上海）有限公司 用于检测肿瘤突变负荷的方法、计算设备和计算机存储介质
CN112185583B (zh) * 2020-10-14 2022-05-31 天津之以科技有限公司 一种基于贝叶斯网络的数据挖掘检疫方法
WO2022103975A1 (en) * 2020-11-12 2022-05-19 Micronoma, Inc. Systems and methods to improve therapeutic outcomes
US12511743B2 (en) * 2020-11-19 2025-12-30 Carnegie Mellon University System and method for detecting and classifying abnormal cells
CN112466389B (zh) * 2020-12-04 2024-05-17 深圳市新合生物医疗科技有限公司 一种基于机器学习算法获取肿瘤标记物的方法和系统
US20220208348A1 (en) * 2020-12-29 2022-06-30 Kpn Innovations, Llc. Systems and methods for producing a homeopathic program for managing genetic disorders
CN114913986B (zh) * 2022-07-15 2022-10-14 四川大学华西医院 一种医疗对象聚类方法、装置、电子设备及存储介质
CN116525105B (zh) * 2023-06-29 2023-10-03 中国人民解放军总医院 一种心源性休克预后预测预警系统、设备及可存储介质
WO2025072084A1 (en) * 2023-09-25 2025-04-03 Foundation Medicine, Inc. Updating records based on consensus annotations of genetic variants
WO2025207817A1 (en) * 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
CN119229980B (zh) * 2024-11-28 2025-02-18 北京大学第三医院（北京大学第三临床医学院） 一种基于机器学习的母源污染去除方法及相关设备

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020077756A1 (en) * 1999-11-29 2002-06-20 Scott Arouh Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
US20020029113A1 (en) * 2000-08-22 2002-03-07 Yixin Wang Method and system for predicting splice variant from DNA chip expression data
EP1394715A1 (en) * 2002-08-02 2004-03-03 Europroteome AG An expert system for clinicial outcome prediction
US7020593B2 (en) 2002-12-04 2006-03-28 International Business Machines Corporation Method for ensemble predictive modeling by multiplicative adjustment of class probability: APM (adjusted probability model)
US9342657B2 (en) * 2003-03-24 2016-05-17 Nien-Chih Wei Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
US7769215B2 (en) 2003-11-28 2010-08-03 The University Of Chicago Method, system, and medium for prevalence-based computerized analysis of medical images and information
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
AU2006234897A1 (en) 2005-03-16 2006-10-19 Sidney Kimmel Cancer Center Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
JP2009505658A (ja) * 2005-08-24 2009-02-12 ブリストル−マイヤーズ スクイブ カンパニー 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
US20100041048A1 (en) * 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
US8386401B2 (en) 2008-09-10 2013-02-26 Digital Infuzion, Inc. Machine learning methods and systems for identifying patterns in data using a plurality of learning machines wherein the learning machine that optimizes a performance function is selected
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US20110166030A1 (en) * 2009-09-30 2011-07-07 Yixin Wang Prediction of response to docetaxel therapy based on the presence of TMPRSSG2:ERG fusion in circulating tumor cells
EP2569626B1 (en) 2010-05-11 2019-11-27 Veracyte, Inc. Methods and compositions for diagnosing conditions
EP2619574B1 (en) * 2010-09-15 2020-10-28 Almac Diagnostic Services Limited Molecular test for predicting responsiveness to dna-damage therapeutic agents in individuals having cancer
PH12013501201A1 (en) * 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
AU2011373694A1 (en) 2011-07-26 2013-05-02 Verinata Health, Inc. Method for determining the presence or absence of different aneuploidies in a sample
RU2014123511A (ru) * 2011-11-10 2015-12-20 Дженентек, Инк Способы лечения, диагностики и мониторинга болезни альцгеймера
US8768668B2 (en) * 2012-01-09 2014-07-01 Honeywell International Inc. Diagnostic algorithm parameter optimization
WO2013151677A1 (en) 2012-04-02 2013-10-10 Broad Institute, Inc. Ddr2 mutations in cancer
US20150278438A1 (en) * 2012-04-23 2015-10-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Genetic predictors of response to treatment with crhr1 antagonists
US20150197785A1 (en) * 2012-08-10 2015-07-16 The Broad Institute, Inc. Methods and apparatus for analyzing and quantifying dna alterations in cancer
CN104781421B (zh) 2012-09-04 2020-06-05 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
CN114574581A (zh) * 2013-03-15 2022-06-03 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
WO2014151117A1 (en) * 2013-03-15 2014-09-25 The Board Of Trustees Of The Leland Stanford Junior University Identification and use of circulating nucleic acid tumor markers
TWI665305B (zh) * 2013-06-11 2019-07-11 美商唐娜 法柏癌症研究所公司 癌症中基因組改變之基於非侵入性血液的檢測
WO2015058175A2 (en) * 2013-10-19 2015-04-23 Trovagene, Inc. Detecting and monitoring mutations in histiocytosis
EP3683321B1 (en) * 2013-10-21 2021-12-08 The General Hospital Corporation Methods relating to circulating tumor cell clusters and the treatment of cancer
EP3736344A1 (en) * 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN107075730A (zh) 2014-09-12 2017-08-18 利兰·斯坦福青年大学托管委员会 循环核酸的鉴定及用途
WO2016094330A2 (en) 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
EP3234841A4 (en) 2014-12-17 2018-08-29 Foundation Medicine, Inc. Computer-implemented system and method for identifying similar patients
WO2016097251A1 (en) * 2014-12-19 2016-06-23 Danmarks Tekniske Universitet Method for identification of tissue or organ localization of a tumour
EP3766986B1 (en) 2014-12-31 2022-06-01 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
EP3288455B1 (en) 2015-05-01 2023-12-06 Guardant Health, Inc. Diagnostic methods
JP6991134B2 (ja) * 2015-10-09 2022-01-12 ガーダント ヘルス， インコーポレイテッド 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
CN110168099B (zh) * 2016-06-07 2024-06-07 加利福尼亚大学董事会 用于疾病和病症分析的无细胞dna甲基化模式

Similar Documents

Publication Publication Date Title
JP2018537754A5 (https=)
US12242943B2 (en) Generating machine learning models using genetic data
US11664126B2 (en) Clinical predictor based on multiple machine learning models
Novielli et al. Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification
ES2970286T3 (es) Plantillas de control de calidad para garantizar la validez de ensayos basados en secuenciación
US20110301863A1 (en) Prediction method for the screening, prognosis, diagnosis or therapeutic response of prostate cancer, and device for implementing said method
CN112951327A (zh) 药物敏感预测方法、电子设备及计算机可读存储介质
US20210166813A1 (en) Systems and methods for evaluating longitudinal biological feature data
KR20210068713A (ko) 딥러닝 기반 다중의료데이터를 통한 질병의 진행 예측 분석 시스템
US10665347B2 (en) Methods for predicting prognosis
US12236346B2 (en) Systems and methods for using a convolutional neural network to detect contamination
KR102389479B1 (ko) 시간 변동 공변량 기반의 prs 모델을 이용한 질환별 위험 유전자 변이 정보 생성 장치 및 그 방법
EP2545481B1 (en) A method, an arrangement and a computer program product for analysing a biological or medical sample
Kokala et al. Bone cancer prediction using regression algorithms and machine learning approaches
CN117766028A (zh) 一种基于甲基化差异预测样本来源的方法及装置
KR20210145539A (ko) 마이크로바이옴을 이용한 건강 정보 제공 방법 및 분석장치
Priyadarshini et al. Developing heart stroke prediction model using deep learning with combination of fixed row initial centroid method with Navie Bayes, Decision Tree, and Artificial Neural Network
JP2022534236A (ja) 多重オミックス分析を利用した鬱病または自殺危険の予測用マーカー発掘方法、鬱病または自殺危険の予測用マーカー、及び多重オミックス分析を利用した鬱病または自殺危険の予測方法
WO2025201556A1 (en) Methylation and aging
CN120636552B (zh) 基于多组学驱动的ibs微生态移植智能预测方法和系统
KR102659915B1 (ko) 환자의 의학적 정보를 예측하기 위한 유전자 선별 방법 및 이의 활용
US20200105374A1 (en) Mixture model for targeted sequencing
KR20250154498A (ko) 백혈구 오염 검출
Perera et al. Alzheimer’s disease prediction using clinical data approach
Ali et al. MACHINE LEARNING IN EARLY GENETIC DETECTION OF MULTIPLE SCLEROSIS DISEASE: ASurvey